Bayer has entered into an alliance with Impli, tapping into the start-up's implantable hormone-monitoring platform, which has potential in fertility treatment and other indications.
A new code of practice has been drawn up in the UK to try to make sure that research on human embryo models derived from stem cells is carried out ethically and responsibly.
